| Literature DB >> 24739137 |
Minoru Nakayama, Tomoki Ishibashi, Hiroyuki O Ishikawa, Hiroyasu Sato, Takao Usui, Takayuki Okuda, Hiroyuki Yashiro, Hironori Ishikawa, Yoshie Taikou, Asako Minami, Kengo Kato, Masataka Taki, Toshiro Aigaki, Wataru Gunji, Masaya Ohtsu, Yasufumi Murakami, Sei-Ichi Tanuma, Alice Tsuboi, Mai Adachi, Junpei Kuroda, Takeshi Sasamura, Tomoko Yamakawa, Kenji Matsuno1.
Abstract
BACKGROUND: Several lines of evidence associate misregulated genetic expression with risk factors for diabetes, Alzheimer's, and other diseases that sporadically develop in healthy adults with no background of hereditary disorders. Thus, we are interested in genes that may be expressed normally through parts of an individual's life, but can cause physiological defects and disease when misexpressed in adulthood.Entities:
Mesh:
Year: 2014 PMID: 24739137 PMCID: PMC4021436 DOI: 10.1186/1471-2156-15-46
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Figure 1A gain-of-function screen to identify reduced-lifespan genes. (A) Crosses for the primary screen: GS lines were crossed with hs-GAL4, and their F1 progeny were raised, at 18°. Typically, 10 to 20 F1 adult males carrying each GS vector and hs-GAL4 were collected for 5 days after eclosion, reared for another 2 days at 18°, and then heat-shocked at 37° for 20 min. The flies were reared for another 5 days at 25°, and then dead flies were counted. Lethality was calculated as the percentage of total heat-shocked flies that were dead flies. (B) A dot plot showing the lethality (determined by the percentage of survivors 5 days after heat shock) of individual lines; the shaded area in the graph corresponds to 80-100% lethality. GS lines with lethality greater than 80% (227 lines, indicated as 1st positive lines) were used for a secondary screen.
Figure 2Comparison of the mean longevity of F1 progeny with or without heat shock. (A and B) The mean longevity of F1 progeny carrying each GS vector and hs-GAL4 was measured with or without heat shock. The numbers of GS lines with the indicated mean longevity are shown for each 2-day period. White and black bars correspond to the number of GS lines treated without (−) or with (+) heat shock, respectively. (A) Mean longevity averages for 122 randomly selected GS lines: the average mean longevity of flies treated without or with heat-shock was 56.6 and 55.2 days, respectively. (B) GS lines misexpressing reduced-lifespan genes, identified from the screen. The average of the mean longevities of flies that were or were not heat-shocked was 3.7 and 38.5 days, respectively. (C and D) Box-and-whisker plots of the mean longevity averages for 122 randomly selected GS lines (C) and lines with reduced-lifespan genes (D), with (+) or without (−) heat shock (hs). Whiskers and outliers were determined by Tukey’s method. Significance indicated (**) is P < 0.001 (unpaired t-test). NS: not significant.
Summary of reduced-lifespan genes
| 11030 | 1.9/63.0 (3.02%) | 3.0/4.1 (−) | |
| 16231 | 1.3/34.6 (3.76%) | 41.6/1.0 (+) | |
| 11124 | 1.9/50.0 (3.80%) | 1.0/2.0 (−) | |
| 10535 | 1.9/48.6 (3.91%) | 2.9/41.3 (−) | |
| 11846 | 2.1/46.0 (4.57%) | ND | |
| 14941 | 3.0/65.1 (4.61%) | 54.9/2.0 (+) | |
| 11121 | 2.0/43.0 (4.65%) | 2.0/3.0 (−) | |
| 16894 | 1.8/36.8 (4.89%) | 1.1/1.0 (−) | |
| 15217 | 2.2/44.8 (4.91%) | 3.0/3.0 (−) | |
| 14710 | 3.0/61.0 (4.92%) | 2.7/3.8 (−) | |
| 13841, 15168 | 2.4/46.7 (5.14%) | 21.3/5.2 (+) | |
| 5211 | 2.6/43.6 (5.96%) | 21.7/4.1 (+) | |
| 11052 | 3.0/49.0 (6.12%) | 8.4/7.0 (−) | |
| 8015 | 3.2/52.0 (6.15%) | 6.8/21.2 (−) | |
| 3250, 15270 | 3.0/48.6 (6.17%) | 11.9/4.1 (−) | |
| 7264, 11283, 17467 | 2.5/36.0 (6.94%) | 2.0/1.7 (−) | |
| 8043, 16669 | 2.0/27.8 (7.19%) | 3.3/3.1 (−) | |
| 7470 | 1.3/16.0 (8.13%) | 31.9/1.0 (+) | |
| 16634 | 3.9/44.8 (8.71%) | 13.9/28.0 (−) | |
| 10711 | 2.8/32.0 (8.75%) | 8.1/2.1 (+) | |
| 10478, 11696, 13072 | 3.4/38.0 (8.95%) | 22.3/36.5 (−) | |
| 9106, 9272, 9689 | 2.6/25.0 (10.40%) | 3.0/2.0 (−) | |
| 11128 | 5.0/45.0 (11.11%) | 11.4/5.4 (−) | |
| 12435 | 3.6/31.0 (11.61%) | 17.4/22.1 (−) | |
| 12449 | 6.7/51.1 (13.11%) | 9.9/41.1 (−) | |
| 12665 | 4.7/34.9 (13.47%) | 34.8/7.8 (+) | |
| 10911 | 7.1/50.4 (14.09%) | 2.8/31.6 (−) | |
| 10668 | 3.9/27.0 (14.44%) | 3.2/4.4 (−) | |
| 14361, 14844, 15232, 15233 | 6.3/41.8 (15.07%) | 3.0/6.6 (−) | |
| 16890 | 4.5/28.3 (15.90%) | 3.9/3.4 (−) | |
| 15946 | 3.3/20.0 (16.50%) | 4.0/9.0 (−) | |
| 9601 | 4.4/26.0 (16.92%) | 36.5/32.5 (−) | |
| 11862 | 8.6/42.2 (20.38%) | 14.9/20.1 (−) | |
| 5065 | 6.1/29.0 (21.03%) | 22.7/14.8 (−) | |
| 15847 | 12.6/57.8 (21.80%) | 21.8/5.0 (+) | |
| 5196 | 2.8/12.1 (23.14%) | 46.9/8.3 (+) | |
| 16440 | 3.1/13.3 (23.31%) | 2.8/17.7 (−) | |
| 11022, 11049 | 2.6/11.0 (23.64%) | 4.5/5.4 (−) | |
| 9799 | 6.8/26.3 (25.86%) | 5.0/28.5 (−) | |
| Average | 4.0/38.5 (10.40%) | 13.5/11.6 |
Representative GS lines used for second screen. The mean longevities are listed on the third column (HS/no-HS).
GS lines used for p35 assay.
Mean longevity (days) of heat-shocked (HS)/not-heat-shocked flies (no-HS).
Mean longevity (days) of flies coexpressing p35 (p35)/or GFP (GFP). (+) indicates longevity extended more than three times by p35 as compared to GFP coexpression.
Disease-related reduced-lifespan genes
| 28 | Alzheimer’s disease, Cancer | ROHN and HEAD [ | ||
| 67 | Diabetes | OMIM *600281 | ||
| 39 | Muscular dystrophy | OMIM *114240 | ||
| 53 | Cancer, Anti-Hu syndrome | SZABO et al. [ | ||
| 42 | Cancer | HIRVONEN-SANTTI et al. [ | ||
| 56 | Spastic paraplegia | OMIM *606439 | ||
| 50 | Huntington’s disease | PHELAN et al. [ | ||
| 52 | Cancer | STREBHARDT [ | ||
| 52 | Cancer | HUDSON et al. [ | ||
| 49 | Fragile X mental retardation | VERKERK et al. [ | ||
| 36 | Zellweger syndrome | OMIM *603360 | ||
| 51 | Distal renal tubular acidosis | OMIM *605239 | ||
| 79 | Cancer | LIU et al. [ | ||
| 36 | ATRX (Xlinked αthalassemia with mental retardation) | OMIM *300032 | ||
| 38 | More than a dozen different inherited diseases, including progeria syndrome | OMIM *150330 | ||
| 66 | Combined oxidative phosphorylation deficiency | OMIM *602389 | ||
| 23 | Familial hemophagocytic lymphohistiocytosis-3 | OMIM *608897 | ||
| 33 | Cancer | BABBAR and CASERO [ | ||
| 46 | Epilepsy | BONAGLIA et al. [ | ||
| 61 | Cancer | HOSOYA et al. [ |
amino acid identity (%) between reduced-lifespan genes and their human orthologs.
Figure 3Inhibiting apoptosis suppressed the reduced lifespan associated with misexpressed reduced-lifespan genes. Survival curves of adult flies expressing UAS-p35 (magenta), which encodes an apoptosis inhibitor, or UAS-GFP (green). Survivor rates are shown for 2-day intervals. (A) Control (Canton-S) flies; (B-D) flies coexpressing the reduced-lifespan gene (B) UAS-rpr, (C) atlastin (misexpression driven by GS12903), or (D) dream (misexpression driven by GS16231).
Expression patterns of GAL4 drivers in adults
| Brain, basiconical sensilla, thoracico-abdominal ganglion, salivary glands | |
| Brain, anterior-midgut, paragonia, salivary glands | |
| Somatic musculature, visceral musculature, salivary glands | |
| Whole gut | |
| Hindgut | |
| Small intestine | |
| Hemocytes | |
| Salivary glands |
Mean longevity of adult flies with the misexpression of reduced-lifespan genes in specific adult tissues
| 11030 | 33.4 | 33.5 | 32.7 | 15.6 | 39.8 | 33.5 | 25.6 | 33.0 | |
| 16231 | 29.1 | 34.7 | 21.8 | 25.2 | 30.9 | (30.0) | |||
| 11124 | 35.4 | 32.5 | 23.4 | 25.1 | 27.9 | 27.9 | 32.1 | ||
| 10535 | 37.8 | 29.1 | 27.7 | 13.8 | 25.3 | 30.2 | 31.6 | 35.5 | |
| 9176 | 30.0 | (37.8) | 23.5 | 17.8 | (19.5) | 21.3 | 23.5 | 29.4 | |
| 14941 | 33.3 | (19.2) | 33.7 | 28.8 | 31.2 | 29.0 | 36.8 | ||
| 11121 | 27.6 | 28.8 | 20.1 | 20.5 | 30.7 | (28.8) | |||
| 16894 | 33.2 | 31.0 | 31.0 | 19.2 | 30.8 | 27.0 | 35.3 | (31.2) | |
| 15217 | 27.9 | 36.3 | 34.4 | 29.1 | 31.7 | 25.5 | |||
| 14710 | 33.3 | 35.3 | 38.2 | 26.7 | 36.9 | 21.0 | 26.6 | 34.3 | |
| 15168 | 33.0 | 32.1 | 23.2 | 29.8 | 26.3 | 35.1 | |||
| 5211 | 27.7 | 31.1 | 30.0 | 12.2 | 33.0 | 26.6 | 31.5 | ||
| 11052 | 20.7 | 18.5 | 11.6 | 22.4 | 19.5 | 21.0 | 33.9 | ||
| 8015 | 24.8 | 33.4 | 12.6 | 18.7 | 32.6 | 17.1 | 36.0 | ||
| 15270 | 22.6 | 33.3 | 20.1 | 17.0 | 11.6 | 29.7 | 36.5 | ||
| 17467 | 35.1 | 27.3 | 16.2 | 17.3 | 31.7 | 30.2 | 42.2 | ||
| 16669 | 25.5 | 17.1 | 13.1 | 14.6 | (27.0) | ||||
| 7470 | 13.1 | 14.8 | 26.8 | 21.9 | 25.5 | 26.7 | |||
| 16634 | 30.9 | 13.6 | 29.6 | 24.3 | 24.9 | 35.1 | 28.8 | 35.6 | |
| 10711 | 27.3 | 38.1 | 16.3 | 22.3 | 26.3 | 16.7 | 29.0 | ||
| 13072 | 18.5 | 13.8 | 13.8 | 15.6 | 25.8 | 33.5 | |||
| 10665 | 21.6 | 23.4 | 29.2 | ||||||
| 11947 | 30.0 | 21.4 | 14.8 | 15.0 | 23.7 | 14.5 | (36.6) | ||
| 12435 | 34.3 | 32.0 | 24.0 | 12.8 | 32.4 | 18.6 | 31.7 | (21.6) | |
| 12449 | 27.3 | 30.4 | 25.4 | 30.5 | 29.4 | 29.0 | |||
| 12665 | 32.1 | 21.7 | 19.2 | 26.4 | 16.4 | 33.6 | 32.4 | 37.0 | |
| 10911 | 35.8 | (35.4) | 34.2 | 26.4 | 24.4 | 29.1 | 35.3 | (37.2) | |
| 10668 | 24.6 | 35.0 | 12.0 | 13.4 | 35.3 | 19.3 | 32.8 | ||
| 15233 | 32.9 | 38.5 | 27.9 | 31.1 | 34.1 | 32.8 | 31.4 | (35.3) | |
| 16890 | 21.5 | 22.5 | 21.6 | 12.2 | 17.8 | 10.9 | 23.9 | ||
| 15946 | 30.6 | 28.4 | 22.8 | 20.6 | 20.6 | 31.4 | 29.9 | 34.4 | |
| 9601 | 26.9 | 34.5 | 11.7 | 16.5 | 31.2 | 34.5 | 18.0 | 45.0 | |
| 11862 | 29.0 | 28.3 | 23.3 | 22.8 | 31.5 | 15.5 | 31.3 | (27.6) | |
| 5065 | 31.1 | 35.0 | 31.5 | 28.1 | 30.2 | 32.1 | 34.7 | ||
| 15847 | 29.5 | 34.2 | 32.6 | 14.7 | 28.1 | 27.2 | 31.7 | 37.8 | |
| 5196 | 38.4 | 28.4 | 33.9 | 12.6 | 30.0 | 35.1 | 28.8 | 32.0 | |
| 16440 | 27.6 | 15.4 | 15.8 | 20.6 | 16.7 | 23.9 | 31.5 | ||
| 11049 | 21.6 | 21.9 | 17.1 | 19.2 | 24.6 | 16.1 | 33.0 | ||
| 9799 | 32.8 | 37.4 | 30.8 | 31.1 | 29.3 | 13.8 | 35.8 | ||
| Canton-S (control) | 37.6 | 32.9 | 34.9 | 31.5 | 31.8 | 35.7 | 28.4 | 34.4 | |
Bold numbers indicate longevity less than 1/3 of control. Parenthetical numbers indicate the mean longevity obtained from fewer than five flies.
Figure 4Misexpression of reduced-lifespan genes in specific tissues was responsible for reduced lifespan in adult flies. Misexpression of reduced-lifespan genes in specific tissues was responsible for reduced lifespan in adult flies. (A-D) Survival curves of adult flies misexpressing reduced-lifespan genes. Tissue-specific expression of reduced-lifespan genes in adult flies was induced with the TARGET system. Survivor rates were scored every three days. (A, B) Two representative reduced-lifespan genes (A) GS5065 (CG11819) and (B) GS10665 (High mobility group protein D) were misexpressed using various GAL4 drivers, indicated in the upper right. (C, D) Survival curves for all identified reduced-lifespan genes when driven by the GAL4 driver (C) 24B-GAL4 or (D) P{GawB}l(3)31-1. Blue lines: survival curve of a wild-type (Canton-S) control. Magenta lines: survival curves showing a lifespan less than 1/3 that of wild-type control flies; the corresponding reduced-lifespan genes are shown in the upper right. Survival curves showing a lifespan greater than 1/3 of that of wild-type control flies are shown in black; the corresponding gene names are not shown.
Significant shared GO terms between reduced-lifespan genes and total genes
| 14320 | GO:0032502 | Developmental process | 3.81E-05 | 16 | 48.5 | 1830 | 17.4 |
| 4795 | GO:0007275 | Multicellular organismal development | 1.78E-04 | 14 | 42.4 | 1620 | 15.4 |
| 22125 | GO:0048513 | Organ development | 3.56E-04 | 10 | 30.3 | 921 | 8.7 |
| 22457 | GO:0048856 | Anatomical structure development | 5.87E-04 | 12 | 36.4 | 1375 | 13.1 |
| 6464 | GO:0009653 | Anatomical structure morphogenesis | 6.05E-04 | 10 | 30.3 | 984 | 9.3 |
| 22337 | GO:0048731 | System development | 6.12E-04 | 11 | 33.3 | 1178 | 11.2 |
| 14319 | GO:0032501|GO:0050874 | Multicellular organismal process | 7.14E-04 | 15 | 45.5 | 2080 | 19.7 |